No Data
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ): Independent Director Han Jiajun has passed away.
Gelonghui reported on February 11 that Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) announced that the Board of Directors learned that independent director Ms. Han Jiajun passed away due to illness on February 10, 2025. During her tenure as an independent director, member of the audit committee, and chairwoman of the nomination committee, Ms. Han Jiajun worked diligently and responsibly, fulfilling her duties and obligations as an independent director with sincerity and loyalty. The Board of Directors expresses gratitude for Ms. Han Jiajun's contributions to the company and mourns her passing.
Should You Be Worried About Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's (SZSE:000766) 1.4% Return On Equity?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's (SZSE:000766) Market Cap Rose CN¥532m Last Week; Retail Investors Who Hold 58% Profited and so Did Insiders
Optimistic Investors Push Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE:000766) Shares Up 27% But Growth Is Lacking
